Why Dr Reddy’s generic weight-loss drug under Olymviq brand won’t hit markets till Friday

The Indian drugmaker gave an oral undertaking to the Delhi High Court after Novo Nordisk alleged trademark infringement of ...

10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt

Dr. Reddy's, Sun Pharma, Zydus & others launch branded generics after patent expiry, targeting a ₹12,000-crore market ...

Dr Reddy's enters semaglutide market, launches diabetes generic drug

Looking to enter India’s ₹1,446 crore glucagon-like peptide (GLP-1) market, Hyderabad-based pharma major Dr Reddy’s Laboratories (DRL) has launched its semaglutide generic, Obeda, for Type 2 diabetes ...
ESPN

DRL's next-gen Racer3 drone combines speed, performance

NEW YORK -- The Drone Racing League unveiled on Thursday the latest edition of its racing drone, which fans will get to see in action on ESPN come June. This is certainly no toy. The DRL Racer3 flies ...
ESPN

DRL's Jawz makes leap from simulator to pro drone racing

Jawz is coming to a TV screen near you. This isn't a shark we're talking about, folks. This is a professional drone racer. Yes, you can now make a living by flying drones. And it looks pretty darn fun ...
EDN

Design challenges in DRL

Dynamically Reconfigurable Logic (DRL) means different things to different people. Generally-speaking though, whenever people refer to 'DRL' they mean any semiconductor technology that can rapidly ...